| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/25/2007 | US20070021406 New neurokinin antagonists for use as medicaments |
| 01/25/2007 | US20070021405 Aryl- and heteroarylpiperidinecarboxylate-derivatives methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | US20070021354 Viricides; immunomoderator; mixture with other Aids drugs |
| 01/25/2007 | US20070020672 Nucleic acid melting analysis with saturation dyes |
| 01/25/2007 | US20070018154 Imidazole derivatives and organic electronic device using the same |
| 01/25/2007 | DE102005033103A1 Heterocyclylamid-substituierte Thiazole, Pyrrole und Thiophene Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/25/2007 | CA2616031A1 Amino acid salts of rosiglitazone |
| 01/25/2007 | CA2615751A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | CA2615420A1 2-arylbenzothiazoles and uses thereof |
| 01/25/2007 | CA2615380A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | CA2615236A1 Substituted piperidine derivatives as somatostatin sst1 receptor antagonists |
| 01/25/2007 | CA2615049A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 01/25/2007 | CA2615045A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 01/24/2007 | EP1746096A1 2-Arylbenzothiazole analogues and uses thereof in the treatment of cancer |
| 01/24/2007 | EP1745044A2 Benzothiazole derivatives having cdk modulating activity and use thereof as anticancer agents |
| 01/24/2007 | EP1745043A1 Process for the preparation of rosiglitazone |
| 01/24/2007 | EP1745040A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 01/24/2007 | EP1745034A1 Vanilloid receptor ligands and their use in treatments |
| 01/24/2007 | EP1745033A2 4,5-disubstituted-2-aryl pyrimidines |
| 01/24/2007 | EP1745032A2 Cxcr1 and cxcr2 chemokine antagonists |
| 01/24/2007 | EP1745029A1 Substituted morpholine compounds for the treatment of central nervous system disorders |
| 01/24/2007 | EP1745023A1 Process for producing bipyridinium compound |
| 01/24/2007 | EP1745009A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives |
| 01/24/2007 | EP1322710B1 Modified carbocyanine dyes and their conjugates |
| 01/24/2007 | EP1040102B1 Arylthiazolidinedione derivatives |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | CN1902196A Thiazole derivative |
| 01/24/2007 | CN1902193A Quinoxalines useful as inhibitors of protein kinases |
| 01/24/2007 | CN1902191A Amidopyrazole derivative |
| 01/24/2007 | CN1902186A Thiazole and pyrazole derivatives as FLT-3 kinase inhibitors |
| 01/24/2007 | CN1902185A Thiazolidinones, their production and use as pharmaceutical agents |
| 01/24/2007 | CN1902168A Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1901917A (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 01/24/2007 | CN1901916A Quinazolinone compounds with reduced bioaccumulation |
| 01/24/2007 | CN1901910A Substituted piperidines for the treatment of metabolic syndrome |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/23/2007 | US7167801 Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166715 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/23/2007 | US7166620 control of phytopathogenic fungi; e.g (E)-3-methoxy-2-{2-[2-(trifluoromethyl)-5-methylthiazol-4-yloxymethyl]-phenyl}acrylate |
| 01/23/2007 | US7166619 Compounds for treatment of diseases associated with prenylation of proteins |
| 01/23/2007 | US7166609 Osteoarthritis; periodontal disease; antiarthritic agents |
| 01/23/2007 | US7166608 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 01/23/2007 | US7166607 Substituted indoles |
| 01/23/2007 | US7166604 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166590 Antiischemic agents; cardiovascular disorders |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | CA2338311C Prodrugs of the pyridyl methyl sulfinyl benzimidazoles |
| 01/23/2007 | CA2164296C Heterocyclic chemistry |
| 01/18/2007 | WO2007009109A2 Antiviral compounds |
| 01/18/2007 | WO2007008895A1 Kinase inhibitors |
| 01/18/2007 | WO2007008501A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/18/2007 | WO2007007886A1 An oxime derivative and preparations thereof |
| 01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | WO2007007656A1 Pharmaceutical composition containing thiazolidinedione compound |
| 01/18/2007 | WO2007007041A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007007040A1 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 01/18/2007 | WO2007006760A1 Dicycloalkyl urea glucokinase activators |
| 01/18/2007 | WO2007006739A1 Benzoheterocyclylethylcarboxamide derivatives |
| 01/18/2007 | WO2007006594A2 Reactive azo dyes, methods for the production thereof and their use |
| 01/18/2007 | WO2007006546A1 Amide derivatives as kinase inhibitors |
| 01/18/2007 | WO2007006534A2 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/18/2007 | WO2005070893A3 Azadecalin glucocorticoid receptor modulators |
| 01/18/2007 | WO2004028441A8 Heterocyclic compound for stimulating or inducing hair or eyelash growth and/or for slowing down hair loss, composition containing same, and uses thereof |
| 01/18/2007 | US20070015819 Novel compounds |
| 01/18/2007 | US20070015804 Protease inhibitor; viricides; purity; crystal structure; mixing tank |
| 01/18/2007 | US20070015802 Inhibitors of cyclin dependent kinases and their use |
| 01/18/2007 | US20070015801 Bactericides; (5R)-(-)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinecarboxamide |
| 01/18/2007 | US20070015797 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 01/18/2007 | US20070015790 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions |
| 01/18/2007 | US20070015788 N-(3-Aryl-3-substitutedphenylpropyl) piperidines or 8-azabicyclo[3.2.1]octanes that are additionally substituted with an optionally fused 5-member N-heterocycle; the compounds are modulators of CCR5 receptor activity and are used in treating diseases such as rheumatoid arthritis |
| 01/18/2007 | US20070015775 Heterocyclic compounds |
| 01/18/2007 | US20070015759 Metasubstituted thiazolidinones, their manufacture and use as a drug |
| 01/18/2007 | US20070015755 Novel compounds and compositions as protease inhibitors |
| 01/18/2007 | US20070015748 Kinase Inhibitors |
| 01/18/2007 | US20070015743 Quinazoline derivatives as antitumor agents |
| 01/18/2007 | US20070015665 Thiazoles derivatives as AMPK activator |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/18/2007 | CA2614691A1 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 01/18/2007 | CA2614518A1 Dicycloalkyl urea glucokinase activators |
| 01/18/2007 | CA2614276A1 Antiviral compounds |
| 01/18/2007 | CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | CA2612765A1 Antidiabetic oxazolidinediones and thiazolidinediones |
| 01/18/2007 | CA2612442A1 Heterotetracyclic compounds as tpo mimetics |
| 01/18/2007 | CA2602389A1 Kinase inhibitors |
| 01/17/2007 | EP1743895A1 Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 01/17/2007 | EP1743885A2 TNF-Alpha Produktion Hemmer zur Behandlung von Autoimmunerkrankungen |
| 01/17/2007 | EP1742943A1 Process of preparing ziprasidone mesylate |
| 01/17/2007 | EP1742942A1 Phenylthioacetic acid derivatives and use thereof |
| 01/17/2007 | EP1742935A1 Polycyclic pyrazines as potassium ion channel modulators |
| 01/17/2007 | EP1742934A2 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 01/17/2007 | EP1742913A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/17/2007 | EP1742909A2 Anionic-sweetener-based ionic liquids and methods of use thereof |
| 01/17/2007 | EP1742906A2 Non-linear optically active molecules, their synthesis, and use |